EIF3A and Burkitt lymphoma: To test whether the molecular insights gained using HLH* EIF3A could have physiological implications in cancer, we generated HLH* EIF3A expressing Ramos Burkitt’s lymphoma cell lines, which are dependent on MYC overexpression for their proliferation [31].